Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma Targeted Therapy

Gilles Salles

MD, PhD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Chief, Lymphoma Service

92
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Gilles Salles is an internationally renowned lymphoma researcher who led the GALLIUM trial establishing obinutuzumab in follicular lymphoma. He has been central to the development of mosunetuzumab and other bispecific antibodies for relapsed FL. His leadership in international cooperative groups has advanced evidence-based FL treatment worldwide.

Share:

🧪Research Fields 研究领域

Mosunetuzumab FL
Bispecific antibody FL
GALLIUM trial
Obinutuzumab
International lymphoma trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Gilles Salles 的研究动态

Follow Gilles Salles's research updates

留下邮箱,当我们发布与 Gilles Salles(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment